A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
Clinical trial NCT02107963 · COMPLETED
Trial details
- NCT number
- NCT02107963
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-28
- Primary completion
- 2016-08-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.